SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-078521
Filing Date
2021-03-12
Accepted
2021-03-12 06:08:00
Documents
4
Period of Report
2021-03-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d113879d8k.htm 8-K 18856
2 EX-99.1 d113879dex991.htm EX-99.1 21347
3 GRAPHIC g113879dsp05.jpg GRAPHIC 3764
4 GRAPHIC g113879dsp05a.jpg GRAPHIC 2526
  Complete submission text file 0001193125-21-078521.txt   50524
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 21735322
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences